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Renal infarction is a rare finding in children. Associations between SARS-CoV-2 infections
and thromboembolic events including renal infarcts have been described in adults.
Although a similar association in children has not yet been described with this pandemic,
the pediatric literature is still evolving with the recognition of new manifestations including
the post-infectious Multisystem Inflammatory Syndrome in Children (MIS-C). We report
the rare event of multiple renal infarcts in a 6-year-old boy manifesting several features
of MIS-C 9 weeks following a self-limiting febrile illness characteristic of COVID-19. An
underlying Factor V Leiden mutation was identified in this child but felt to be insufficient
on its own to explain his clinical presentation. As SARS-CoV-2 testing was delayed,
the failure to identify viral RNA or antibodies may not exclude the virus’ potential role
in precipitating the infarct in this host. Given that renal infarcts have been described in
adult patients with COVID-19, reporting this perplexing case where SARS-CoV-2 may
have played a role, may help identify this potential complication.
Keywords: renal infarct, multisystem inflammatory syndrome in children, pediatric inflammatory multisystem
syndrome, COVID-19, SARS-CoV-2, merged SPECT/CT

BACKGROUND
Acute renal infarcts in children are rare and relate to cardiac conditions (atrial fibrillations/flutter,
or valve vegetations), thrombi from atheroma, renal artery dissection, fibromuscular dysplasia,
hypercoagulability, renal trauma, and rare systemic or infectious diseases (1). They are usually
embolic and observe segmental morphology as a function of renal anatomy, resulting in a
wedge-shaped region of decreased enhancement in MRI or CT imaging (2). In a systematic review
of the adult literature, 45% of renal infarction was caused by cardiac reasons or aortic embolism,
16% arterial injury, 9% prothrombotic factors in 9 and 21% miscellaneous or idiopathic (3).
Recently, COVID-19 infections have been added to the list of causes for renal infarcts (4–7).

CASE REPORT
A previously healthy 6-year-old Middle Eastern boy with a negative history of consanguinity,
antenatal anomalies of the urinary tract or urinary tract infections, presented with a one-day
history of severe abdominal/right-sided flank pain, vomiting and fever (40.5◦ C). Parents denied
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trauma, dysuria, Kawasaki-like features, or recent ill contacts.
Nine weeks earlier, he had a self-limiting 7-day-febrile illness with
pharyngitis, dry cough and myalgia. No SARS-CoV-2 testing was
performed at that time.

antiphospholipid antibody syndrome and hyperhomocystinemia
were negative. However, the patient tested positive for a
heterozygous factor V Leiden mutation (c.1691G>A) (FVL).
Urinalysis showed transient microhematuria, and urine cultures
remained sterile. SARS-CoV-2 PCR was negative for the patient
as were anti-SARS-CoV-2 total, IgG and IgA assays for the patient
and his family.

Labs
The initial white blood cell count was 16.0∗ 10∧ 9/L (normal ∗ 5.0–
12.0) without a left shift and platelets peaked at 664∗ 10∧ 9/L
on day 10. Transaminases, albumin, creatine kinase, lactase
dehydrogenase and troponin were normal. Serum creatinine
was not elevated and the improved Schwartz formula eGFR
was normal. C-reactive protein peaked at 340.0 mg/L (normal
<5.0) and ferritin was 285 ug/L. Fibrin D-dimer was 2,843 ug/L
(normal <499). Lupus serology, anti-thrombin, protein C and
S assays, p and c-ANCA, rheumatoid factor and lipid profile
were all normal. Interferon-gamma release assay and workup for

Imaging
Chest X-ray and echocardiogram were normal. The abdominal
ultrasound showed no evidence for appendicitis or renal lesions.
His abdominal CT demonstrated abnormal peripheral hypoenhancing areas in the upper pole of the right kidney (Figure 1).
An MRI pre- and post-gadolinium also demonstrated multiple
wedge-shaped areas of decreased enhancement in the right
upper pole. Both MRI and CT raised concerns for systemic

FIGURE 1 | Representative fused SPECT/CT images of Tc99m-DMSA scan. CT scan was obtained with IV contrast. Images demonstrate wedge-shaped cortical
defect involving the superior pole of the right kidney compatible with infarct. Two additional, smaller defects were also visualized in the lower and mid poles (not
shown). Upper row: CT images, Middle row: Tc99m –DMSA scan and Lower row: fused SPECT/CT images in coronal, sagittal and axial projections.
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• Exclusion of any other microbial cause, including bacterial
sepsis, staphylococcal or streptococcal shocksyndromes,
infections associated with myocarditis such as enterovirus.
• Proof of recent SARS-CoV 2 infection (positive pCR or
antibody test) or epidemiological link.
As such, our patient would meet the definition. However,
testing for SARS-CoV-2 antibodies was negative 12 weeks
post-COVID-19-like illness. Interpretation of these results are
challenging given that the serology results may be falsely
negative or become negative because of waning immunity
over time (18, 19). Furthermore, laboratory evidence of recent
or past SARS-CoV-2 infection may be lacking in children
with MIS-C (15). In view of his antecedent illness and no
other identified risk factor for his renal infarcts, we wonder
if this perplexing case may be related to a past SARS-CoV-2
infection, as it has been described in adults (5, 7). MIS-C and
other COVID-19-related events may be underreported given
the limitation of diagnostic tests to confirm past COVID19 infections in children. Renal infarction is such a rare
event in otherwise healthy children as well as those with FVL
mutations, that when associated with a febrile multisystem
illness during the pandemic there should be a high index
of suspicion about MIS-C triggering thrombotic events, even
without the confirmed presence of SARS-CoV-2 antibodies.
It is our hope that reporting this case increases the body of
evidence about this rare pediatric condition.

autoinflammatory process given the finding of bilateral small
volume pleural effusions, ascites, appendiceal inflammation and
distended gall bladder. No vessel abnormalities were detected,
especially no aneurysms. Tc 99-DMSA renal scan demonstrated a
normal cortical uptake on the left kidney whereas the right kidney
demonstrated wedge-shaped defects in the posterior aspect of the
upper pole (Figure 1).
Empiric ceftriaxone was discontinued as all cultures were
sterile. Fever and pain persisted for 7 days. The final diagnosis
was idiopathic acute renal infarction. On follow up, the patient
remained asymptomatic and was kept on 81 mg of Aspirin for
6 months.

DISCUSSION
This 6-year-old boy suffered acute renal infarctions without a
clear identifiable etiology. Abdominal pain, flank pain, nausea,
vomiting, fever as well as the course of the C-reactive protein and
the D-dimer are typical characteristics of acute renal infarction
(1). The only disposing factor was a heterozygous state for
factor V Leiden c.1691G>A mutation, and while this condition
has been associated with neonatal renal vein thrombosis (8),
thrombotic events on the arterial side are very rare outside
of renal transplantation. Thrombophilia in idiopathic renal
infarction has been reported primarily in older adults, and related
to antiphospholipid antibody syndrome, hyperhomocystenemia,
or combined thrombophilias (1, 9–11). While there have been
conflicting studies, particularly in children, two large metaanalyses have shown no association between FVL and arterial
thrombosis (9, 12). While it is possible that FVL may have
interacted with other genetic and environmental factors, it is our
opinion that this mutation on its own is unlikely to have been the
reason for the renal infarcts.
In the context of the COVID-19 pandemic, given this patient’s
multi-visceral inflammation and antecedent illness consistent
with COVID-19, the multi-system inflammatory syndrome in
children (MIS-C) was considered. Several countries affected by
the coronavirus disease (COVID-19) pandemic recently reported
cases of children that were hospitalized in intensive care due to a
rare MIS-C, also known as pediatric inflammatory multisystem
syndrome (PIMS). The presenting signs and symptoms are a
mix of the ones for Kawasaki disease and toxic shock syndrome
and are characterized, among others, by fever, abdominal pain
and cardiac involvement (13, 14). Kidney involvement has been
described, (15) albeit in most cases as acute kidney injury (16). On
1 May 2020, the Royal College of Paediatrics and Child Health
published a guidance document on the clinical management of
children presenting with PIMS-TS and proposed the following
case definition (17):
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• A child presenting with persistent fever, inflammation
(neutrophilia, elevated CRP and lymphopaenia) and evidence
of single or multi-organ dysfunction (shock, cardiac,
respiratory, renal, gastrointestinal orneurological disorder)
with other additional clinical, laboratory or imaging and ECG
features. Children fulfilling full or partial criteria for Kawasaki
disease may be included.
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